Fatty Liver Disease Fuels Cancer Risk; Biomarkers Offer Early Detection Hope

• Liver cancer, including HCC, is a leading cause of cancer deaths, often detected late due to symptomless early stages.
• Risk factors range from infections like Hepatitis B/C to lifestyle choices such as excessive alcohol, smoking, obesity, and unhealthy diet.
• Non-alcoholic fatty liver disease (NAFLD), linked to obesity, is a growing global concern significantly increasing liver cancer risk.
• Beyond traditional scans, new blood and genetic tests are being explored for earlier detection of liver cancer.
• Biomarkers, special molecules in blood, are crucial for predicting, early detecting, and personalizing treatment for liver cancer.

Why It Matters: Early detection via biomarkers is crucial for managing liver cancer, especially with rising fatty liver disease.